AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saltzman, J. R
Right arrow Articles by Goldin, B. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saltzman, J. R
Right arrow Articles by Goldin, B. R
Agricola
Right arrow Articles by Saltzman, J. R
Right arrow Articles by Goldin, B. R
American Journal of Clinical Nutrition, Vol. 69, No. 1, 140-146, January 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

A randomized trial of Lactobacillus acidophilus BG2FO4 to treat lactose intolerance1,2,3,4,5

John R Saltzman, Robert M Russell, Barbara Golner, Susan Barakat, Gerard E Dallal and Barry R Goldin

Background: Lactose intolerance is the most common disorder of intestinal carbohydrate digestion. Lactobacillus acidophilus BG2FO4 is a strain of lactobacilli with properties of marked intestinal adherence and high ß-galactosidase activity.

Objective: This study was designed to determine whether oral feeding of Lactobacillus acidophilus BG2FO4 leads to a lactose-tolerant state.

Design: We studied 42 subjects with self-reported lactose intolerance and performed breath-hydrogen tests to determine whether they were lactose maldigesters. Subjects with established lactose maldigestion (n = 24) were invited to be randomly assigned to an omeprazole-treated (hypochlorhydric) group or a non-omeprazole-treated group, but 6 subjects chose not to participate. All randomly assigned subjects (n = 18) ingested Lactobacillus acidophilus BG2FO4 twice per day for 7 d and stool samples were collected. Breath-hydrogen tests were performed and symptom scores were recorded at baseline and after lactobacilli ingestion.

Results: Lactose maldigestion was established in 24 of 42 subjects (57%) with self-reported lactose intolerance. In 18 lactose-maldigesting subjects, overall hydrogen production and symptom scores after ingestion of Lactobacillus acidophilus BG2FO4 were not significantly different from baseline values. Live Lactobacillus acidophilus BG2FO4 was recovered in stool samples from 7 subjects.

Conclusions: Lactose intolerance is overreported in subjects with gastrointestinal symptoms after lactose ingestion. Treatment of lactose-maldigesting subjects with and without hypochlorhydria with Lactobacillus acidophilus BG2FO4 for 7 d failed to change breath-hydrogen excretion significantly after lactose ingestion.

Key Words: Lactose intolerance • Lactobacillus acidophilus • breath-hydrogen test • omeprazole • hypochlorhydria • humans




This article has been cited by other articles:


Home page
J Biomol ScreenHome page
A. Piepoli, E. Schirru, A. Mastrorilli, A. Gentile, R. Cotugno, M. Quitadamo, A. Merla, M. Congia, P. U. Satta, and F. Perri
Genotyping of the Lactase-Phlorizin Hydrolase C/T-13910 Polymorphism by Means of a New Rapid Denaturing High-Performance Liquid Chromatography-Based Assay in Healthy Subjects and Colorectal Cancer Patients
J Biomol Screen, August 1, 2007; 12(5): 733 - 739.
[Abstract] [PDF]


Home page
J. Nutr.Home page
D. A. Savaiano, C. J. Boushey, and G. P. McCabe
Lactose Intolerance Symptoms Assessed by Meta-Analysis: A Grain of Truth That Leads to Exaggeration
J. Nutr., April 1, 2006; 136(4): 1107 - 1113.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
D M Swallow, K-L Kolho, I Jarvela, and M E Weale
DNA test for hypolactasia premature * Authors' reply * Author's reply
Gut, January 1, 2006; 55(1): 131 - 132.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
H. Y. Lovelace and S. I. Barr
Diagnosis, Symptoms, and Calcium Intakes of Individuals with Self-Reported Lactose Intolerance
J. Am. Coll. Nutr., February 1, 2005; 24(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Rasinpera, E Savilahti, N S Enattah, M Kuokkanen, N Totterman, H Lindahl, I Jarvela, and K-L Kolho
A genetic test which can be used to diagnose adult-type hypolactasia in children
Gut, November 1, 2004; 53(11): 1571 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J M T Hamilton-Miller
Probiotics and prebiotics in the elderly
Postgrad. Med. J., August 1, 2004; 80(946): 447 - 451.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
T. H. Vesa, P. Marteau, and R. Korpela
Lactose Intolerance
J. Am. Coll. Nutr., April 1, 2000; 19(90002): 165S - 175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Peuhkuri, H. Vapaatalo, R. Korpela, and U. Teuri
Lactose intolerance--a confusing clinical diagnosis
Am. J. Clinical Nutrition, February 1, 2000; 71(2): 600 - 602.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Szilagyi
Prebiotics or probiotics for lactose intolerance: a question of adaptation
Am. J. Clinical Nutrition, July 1, 1999; 70(1): 105 - 106.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society for Nutrition